Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Plerixafor Off-Label Use in the European Group for Blood and Bone Marrow Transplantation (EBMT) Registry

NCT01362985 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT01362985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01362985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Plerixafor Off-Label Use in the European Group for Blood and Bone Marrow Transplantation (EBMT) Registry
Lead sponsor
Genzyme, a Sanofi Company
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
July 31, 2014
Enrollment
201 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, chronic leukemia, lymphoma, myelodysplastic syndrome, myeloproliferative neoplasm, plasma cell disorders, solid tumors